Table 5 The result of evaluation (main study) conducted to evaluate the effect on increase & decrease of reverse mutation colonies by the addition of 7%-GNANA, a test substance, under the presence and absence conditions of metabolic activation system
With and without metabolic activation | Test material conc.(μg/plate) | Number of revertant colony (cfu/plate) |
Base substitution types | Frameshiftm types |
TA100* | TA1535* | WP2uvrA* | TA98* | TA1537* |
S9 Mix(-) | 0 | 124.3± 2.31# | 25.7±2.31# | 24.7±1.53# | 32.0±1.73# | 13.7±2.08# |
61.7 | 111.3± 7.77 | 25.7±2.08 | 26.0±5.00 | 34.0±2.65 | 13.0±1.00 |
185 | 115.7±12.66 | 25.0±2.00 | 27.3±2.08 | 35.3±1.53 | 13.7±0.58 |
556 | 132.0±13.00 | 27.7±2.08 | 26.7±3.21 | 39.0±1.00 | 14.7±2.89 |
1,670 | 119.3± 7.51 | 26.0±5.00 | 26.7±3.79 | 36.7±0.58 | 13.3±0.58 |
5,000 | 128.7±10.97 | 28.3±2.89 | 24.0±1.00 | 37.3±2.08 | 13.3±0.58 |
S9 Mix(+) | 0 | 134.7± 0.58 | 24.0±1.73 | 25.3±1.53 | 35.7±1.53 | 14.7±2.52 |
61.7 | 120.0± 2.65 | 23.3±3.21 | 25.0±6.93 | 38.3±2.08 | 13.7±1.53 |
185 | 117.7± 1.15 | 24.0±3.61 | 25.7±3.79 | 37.0±2.65 | 12.7±3.06 |
556 | 109.7± 8.96 | 22.0±1.00 | 28.0±4.00 | 37.0±3.61 | 13.0±1.00 |
1,670 | 125.7± 7.77 | 23.3±4.93 | 29.3±1.53 | 33.7±4.73 | 13.0±1.00 |
5,000 | 125.7±13.20 | 27.0±2.65 | 29.7±4.16 | 36.7±2.52 | 13.7±0.58 |
Positive control | S9 Mix(-) | Materialds | NaN3 | NaN3 | 4-NQO | 4-NQO | 9-AA |
Conc. (μg/plate) | 1.5 | 1.5 | 0.5 | 0.5 | 80 |
cfu/plate | 442.3±10.26 | 237.0±13.53 | 241.3±25.01 | 287.3±15.14 | 272.7±9.87 |
S9 Mix(+) | Materialds | 2-AA | 2-AA | 2-AA | 2-AA | 2-AA |
Conc. (μg/plate) | 1.0 | 2.0 | 10 | 0.5 | 2.0 |
cfu/plate | 406.7±3.51 | 241.0±14.11 | 344.7±9.50 | 265.7±17.62 | 290.0±23.43 |
*: TA98 (Sal. typhimurium TA98), TA100 (Sal. typhimurium TA100), TA1535 (Sal. typhimurium TA1535), TA1537 (Sal. typhimurium TA1537), WP2uvrA (E. coli WP2uvrA), #: Represents a significant difference at p<0.01 level compared with the vehicle control